Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001186120-05-000014
Filing Date
2005-03-21
Accepted
2005-03-21 14:57:44
Documents
2
Period of Report
2005-03-17

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 3734
2 EDGAR SUPPORTING DOCUMENT mathews.txt EX-24 764
  Complete submission text file 0001186120-05-000014.txt   6505
Mailing Address 11388 SORRENTO VALLEY ROAD SUITE 200 SAN DIEGO CA 92121
Business Address 11388 SORRENTO VALLEY ROAD STE 200 SAN DIEGO CA 92121 8586225200
AVANIR PHARMACEUTICALS (Issuer) CIK: 0000858803 (see all company filings)

EIN.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 11388 SORRENTO VALLEY RD STE 200 SAN DIEGO CA 92121
Business Address
MATHEWS CHARLES (Reporting) CIK: 0001190315 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15803 | Film No.: 05694004